23-07-2017 08:44:13

12th Danish Conference on Biotechnology and Molecular Biology (DCB12)

Theme: CRISPR based technologies and bio-products. Please note, registration here is for delegates only. Please find information for invited speakers, poster presenters and exhibitors at http://www.biokemi.org/meetings/122.
Arrangør: IDA Bioteknologi

This page is for registration of delegates. For upload of abstracts  (posters and invited speakers) and , registration of invited speakers and exhibitors please refer to http://www.biokemi.org/meetings/122

Genome editing and the utilization of CRISPR based technologies are expected to revolutionize the production of the next generation of bioproducts. DCB12 will focus on the latest developments in the use of CRISPR/Cas9 and other CRISPR based technologies in relation to the development and production of biopharmaceuticals, biochemicals, agricultural crops and translational applications. The conference will include sessions on:

The conference will include sessions on CRISPR based research in
-  Drug screening
-  Production of bio-pharmaceuticals
-  Therapeutics
-  Plant cell factories and agro-science
-  Mammalian and microbial cell factories
-  Legal and regulatory aspects
-  Tools and future directions

Accepted speakers
  Alex Toftegaard Nielsen, The Technical University of Denmark, DK
  Birger Lindberg Møller, University of Copenhagen, DK
  Claudio Mussolino, University Medical Center Freiburg, D
  Jon Chesnut, Thermo Fisher Scientfic, USA
  Mark Behlke, Integrated DNA Technologies, USA

Invited speakers
  Gregory Davis, Millipore Sigma, USA
  Helene Faustrup Kildegaard, NNF Biosustainability Centre, The Technical University of Denmark, DK
  Jeff Boeke, New York University, Langone Medical Center, USA
  Jennifer Doudna, Department of Molecular and Cell Biology, University of California, Berkeley, USA
  Laurent Poirot, Cellectis, F
  Lorenz Mayer, AstraZeneca, UK
  Pascal Daran-Lapujade, Delft University, NL
  Philip Webber, Dehns Patent & Trade Mark Attorneys, UK
  Philippe Horvath, DuPont-Danisco, F
  Sofia Håkansson Buch, Novo Nordisk A/S, DK

Conference fee
The registration fee covers the entire conference stay and includes participation in the scientific programme, the announced meals  and conference dinner,  and accommodation for Thursday night.

The conference is organised in collaboration with IDA Biotechnology/DBS and Danish Society of Biochemistry and Molecular Biology and includes a poster session as well as a commercial exhibition of equipment, consumables and services to Danish biotechnology.

Tilvalg

Ledsager
kr. 0

Kommende arrangementer
fra IDA Bioteknologi

2 nov.
Udvikling af fremtidens høreapparater og måling af blodtryk med ultralyd
  • EY Huset, Aarhus C
  • torsdag d. 02. november kl. 16:45

Netværk

Få højt specialiseret viden og rabat på arrangementer, som medlem af IDAs 40 fagtekniske netværk.

Meld dig ind i et netværk

luk
close